Observational study on infections in transplant patients in Germany

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study collects medical data and biological samples from transplant patients across Germany to investigate the factors influencing organ susceptibility to infections and overall function. It aims to understand the long-term consequences of infections on graft survival and the role of individual susceptibility under immunosuppression. By establishing a large multicenter cohort, the study will facilitate scientific research into the connections between infections, immune response, and transplant outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Consent
* undergone transplantation of kidney, pancreas, liver, heart or stem cells

Exclusion Criteria:

* No consent

Where it's running

• Technische Universität München
  München, Germany Recruiting

Study contacts

• Study coordinator: Daniela Schindler, Dr.
• Email: daniela.schindler@tum.de

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

• Metabolic and Functional Study of γδ T Cells in Critically Ill Patients

  Researchers will look at how γδ T cells behave in severely ill patients, including those with sepsis, to see how their metabolism and function change.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Outside of the US · NCT07680816

• Cardiovascular outcomes after hematopoietic stem cell transplantation

  We will collect clinical, laboratory, and treatment data from people who had hematopoietic stem cell transplants to see if certain factors are linked to heart and blood vessel problems after transplant.

  Recruiting at 16 sites Peking University People's Hospital · Beijing, Beijing Municipality and 15 other locations · NCT07349498

• Using FibroScan to guide lowering immune-suppressing drugs after liver transplant

  This will test whether using FibroScan to measure liver stiffness lets doctors safely reduce immunosuppressive drugs in adults at least 2 years after a liver transplant who don't have autoimmune liver disease or recent rejection.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07206277

• Negative-pressure wound dressing after kidney transplant

  This study tests whether using a negative-pressure wound dressing right after open kidney transplant reduces wound problems for adult transplant recipients.

  Recruiting Phase 4 Centro Hospitalar De São João, E.P.E. · Porto · NCT07065734

• Preemptive genetic testing to guide tacrolimus treatment for kidney transplant patients

  This study will test whether doing a genetic test before transplant to guide tacrolimus dosing helps people on the kidney transplant waiting list stay safer and use health resources more efficiently.

  Recruiting Phase 4 Instituto de Investigación Hospital Universitario La Paz · Madrid, Madrid · NCT06701825

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.